BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 14, 1997
View Archived Issues
New compounds for heparin reversal disclosed by University of Michigan
Read More
Merck & Co. discloses novel antifungal agents
Read More
Thomae reports agents for hypercholesterolemia
Read More
More oxazolidinone antimicrobial agents under study at P&U
Read More
Neurogen reports CRF ligands for stress-related disorders
Read More
Chiroscience reports new peptidyl compounds for treating degenerative diseases
Read More
Nitric oxide synthase inhibitors reported by Searle
Read More
Company Profile: NeoTherapeutics, Inc.
Read More
cGMP PDE inhibitors from Taisho
Read More
Kao discloses cell adhesion inhibitors
Read More
Thomas Jefferson University claims new apoptotic cysteine protease
Read More
Genetics Institute reports new bone morphogenic protein
Read More
Amgen discloses novel eck receptor ligands
Read More
New Canadian generic joint venture
Read More
Carrington Laboratories enters Middle East and African markets
Read More
HemoCleanse licenses bioartificial liver technology from Monsanto
Read More
Canadian launch for antiobesity drug
Read More
Ion exercises option to license sickle cell anemia Rx
Read More
Cell Genesys and Somatix to merge
Read More
Subcutaneous BDNF not effective in ALS
Read More
Avid licenses protease inhibitor from DuPont Merck
Read More
Approval for Neoprobe's first product
Read More
Gliatech licenses ADCON products in Japan
Read More
Annual review of activities at Collagen Corp.
Read More
FDA to review AmBisome NDA
Read More
Company Profile: Houghten Pharmaceuticals
Read More
Second IND submitted for new ADHD therapy
Read More
